| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 11/24/2005 | US20050260233 Attenuated vaccine useful for immunizations against Coccidioides spp. infections |
| 11/24/2005 | US20050260232 Attenuated Mycobacterium tuberculosis vaccines |
| 11/24/2005 | US20050260228 Vaccines absorbable by the transmucosal way |
| 11/24/2005 | US20050260223 Salmonella vaccine materials and methods |
| 11/24/2005 | US20050260218 House dust mite allergen, Der f VII, and uses therefor |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260197 Receptor for Oncostatin M |
| 11/24/2005 | US20050260182 obtained from endophytic Streptomycetes isolated from higher plants; biological activity against plant pathogensPythium ultimum, Phytophthora cinnamomi, Cryptococcus neoformans, Candida albicans; parasitic Plasmodium falciparum; bacterial pathogen, Streptococcus pneumoniae; breast epithelial cancer cell |
| 11/24/2005 | US20050260170 Bifidobacteria preventing diarrhea caused by pathogenic bacteria |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | CA2567109A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 11/24/2005 | CA2567106A1 Self-containing lactobacillus strain |
| 11/24/2005 | CA2566517A1 Improved konjac glucomannan cellulase hydrolysate prebiotics |
| 11/24/2005 | CA2566415A1 Methods and compositions for the dietary management of autoimmune disorders |
| 11/24/2005 | CA2565247A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 11/24/2005 | CA2562171A1 Mutant .alpha.-amylases |
| 11/23/2005 | EP1598422A2 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 11/23/2005 | EP1598416A1 Method for producing L-amino acid |
| 11/23/2005 | EP1598363A1 Protein regulating the concentration of calcium in endoplasmic reticulum |
| 11/23/2005 | EP1598122A1 Method of treating organic waste, agent for treating organic waste and microorganisms to be used therein |
| 11/23/2005 | EP1597381A2 Production of modified glycoproteins having multiple antennary structures |
| 11/23/2005 | EP1597364A2 Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways |
| 11/23/2005 | EP1597354A2 System for external control of oncolytic virus replication |
| 11/23/2005 | EP1597353A2 CIRCULATING TUMOR CELLS (CTC's): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
| 11/23/2005 | EP1597352A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 11/23/2005 | EP1597351A2 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES |
| 11/23/2005 | EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 11/23/2005 | EP1597349A2 Methods of screening for trpm5 modulators |
| 11/23/2005 | EP1597348A2 Conserved and specific streptococcal genomes |
| 11/23/2005 | EP1597285A2 Rubber treatment method |
| 11/23/2005 | EP1597275A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 11/23/2005 | EP1322751B1 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 11/23/2005 | EP1196592B1 Expression system for the production of proteins in fungi |
| 11/23/2005 | EP0983363B1 Phosphatidyl-3,4.5-triphosphate-dependent protein kinase |
| 11/23/2005 | EP0939817B1 High-affinity interleukin-4 muteins |
| 11/23/2005 | EP0871760B1 Recombinant production of novel polyketides |
| 11/23/2005 | EP0792347B1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 11/23/2005 | CN1701119A Methods for increasing the production of a recombinant polypeptide from a host cell |
| 11/23/2005 | CN1701116A Probiotic bacterium: lactobacillus fermentum |
| 11/23/2005 | CN1699554A Mycobacterium Smegmatis preparation and use thereof |
| 11/23/2005 | CN1699553A Sulfate-resistant Rhodococcus erythropolis and use thereof |
| 11/23/2005 | CN1699552A Beer yeast engineering strain and its construction method |
| 11/23/2005 | CN1699551A Beer yeast engineering strain and its construction method |
| 11/23/2005 | CN1699550A High density fermentation method for GS115/PFK-K5 |
| 11/23/2005 | CN1699549A Xylaria nigripes and its purification, separation, extraction and rejuvenation preservation technology |
| 11/23/2005 | CN1699548A Method for improving algae biomass and yield of biologicalactivity product thereof |
| 11/23/2005 | CN1699547A Gordona terrae C-6 and its desulfurization effect |
| 11/23/2005 | CN1228450C Antigenic preparations |
| 11/23/2005 | CN1228445C Bacterium and method for producing L-amino acid |
| 11/23/2005 | CN1228441C Prevotella Shan and Collins S-1 and process for prepn. of metabolites of ginseng saponins |
| 11/23/2005 | CN1228440C Method for preparing young pine infected by armillaria matsutake |
| 11/23/2005 | CN1228439C Method for fermenting edible and medical mushroon liquid |
| 11/23/2005 | CN1228438C Natural additive for promoting white-rot fungi in liquid culture medium |
| 11/23/2005 | CN1228437C Penicillium commune |
| 11/22/2005 | US6967246 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 11/22/2005 | US6967245 Ucp5 |
| 11/22/2005 | US6967101 Surface and its manufacture and uses |
| 11/22/2005 | US6967099 Plant-fiber containing composition for anaerobic bioremediation |
| 11/22/2005 | US6967097 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases |
| 11/22/2005 | US6967094 Peptide for use in treatment of cancer, parkinson's and metabolic disorders |
| 11/22/2005 | US6967092 Multi-functional chimeric hematopoietic receptor agonists |
| 11/22/2005 | US6967090 Nucleic acid and protein sequences of bovine epidermal growth factor |
| 11/22/2005 | US6967088 Soluble recombinant botulinum toxin proteins |
| 11/22/2005 | US6967087 Obligately symbiotic thermophile symbiobacterium toebii SC-1 producing thermostable L-tyrosine phenol-lyase and L-tryptophan indole-lyase and a method for screening its relative bacteria |
| 11/22/2005 | US6967085 a first cationic polymer that has intrinsic viscosity of not more than 2 dl/g, (e.g., polydiallyldimethylammonium chloride) and a second polymer, which is cationic or non-ionic and has inintrinsic viscosity of at least 4 dl/g |
| 11/17/2005 | WO2005108581A1 Recombinant virus vector for gene introduction in lymphocyte |
| 11/17/2005 | WO2005108574A1 Gm1 PROMOTER AND USE THEREOF |
| 11/17/2005 | WO2005108570A1 Nucleic acid/enzyme complex |
| 11/17/2005 | WO2005108553A1 Method for culturing the nitrile hydratase-producing strain rodococcus rhodochrous m33 |
| 11/17/2005 | WO2005108552A1 Mutant saccharomyces cerevisiae strain utilizing xylose for ethanol production |
| 11/17/2005 | WO2005093045A3 Cell concentration and pathogen recovery |
| 11/17/2005 | WO2005049644A3 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system |
| 11/17/2005 | WO2005026331A3 Method of preparation of pharmaceutically grade plasmid dna |
| 11/17/2005 | WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 11/17/2005 | WO2004070006A3 Nucleic acid antigens embedded in thermoplastic |
| 11/17/2005 | WO2003087321A8 Plant acyl-coa synthetases |
| 11/17/2005 | WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 11/17/2005 | WO2001072768A8 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 11/17/2005 | US20050256303 Having antibacterial activity, antioxidative effect, inflammation inhibitory effect, in vivo substance transporting action, and enzymatic activity, used as a drug administration carrier |
| 11/17/2005 | US20050256042 Methods of preventing and treating alimentary mucositis |
| 11/17/2005 | US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 11/17/2005 | US20050255572 Culturing escherichia , defective in pyruvate dehydrogenase (PDH) activity, in presence of glucose and acetate, recover accumulated metabolites |
| 11/17/2005 | US20050255571 Biocatalysts in chemical reactions, activity, stability and enantioselectivity; for the preparation of optically active compounds |
| 11/17/2005 | US20050255568 Methods and compositions for amino acid production |
| 11/17/2005 | US20050255567 Mutant glutamine synthetase and method for producing amino acids |
| 11/17/2005 | US20050255559 Isolated nucleic acid molecule(s) encoding a human calcium sensitive potassium channel subunit protein designated beta2, encoded proteins, and uses thereof |
| 11/17/2005 | US20050255558 Signal sequence polypeptides for diagnosis, prevention and treatment of metabolic disorders |
| 11/17/2005 | US20050255557 Novel compounds |
| 11/17/2005 | US20050255549 IRAK-4: compositions and methods of use |
| 11/17/2005 | US20050255531 Signal transduction |
| 11/17/2005 | US20050255497 Gene for coding thermostable L-arabinose isomerase and method for producing the same |
| 11/17/2005 | US20050255469 Human 5-ht7 receptor promoter sequence |
| 11/17/2005 | US20050255450 contacting a yeast cell with a candidate agent, wherein the yeast cell expresses an alpha synuclein polypeptide and the cell does not express an endogenous wild-type gene, which causes or enhances toxicity associated with the presence of the alpha synuclein polypeptide |
| 11/17/2005 | US20050255193 Milk fermented in presence of lactic acid bacteria growth factor by at least one lactic acid bacteria such as Lactobacillus casei, Lactobacillus acidophilus, wherein bacteria growth factor is selected from ginger extract, green onion extract, and tea extract; improved viability of lactic acid bacteria |
| 11/17/2005 | US20050255190 Method for processing cereal material |
| 11/17/2005 | US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 11/17/2005 | US20050255093 treating nervous system disorders induced by stroke or injury, injured by trauma to reduce oxidative stress, administering a conjugate of antioxidant enzyme and a clostridial neurotoxin cell binding domain, and a clostridial neurotoxin translocation domain; tissue-targeted therapy |
| 11/17/2005 | US20050255092 an isolated microorganism of the genus Bacillus that is capable of inhibiting escherichia coli disease and improving performance of an animal (pigs); antidiarrhea andantiedemic agents |
| 11/17/2005 | US20050255090 High enzyme activity; screening its relative symbiotic bacteria using a specific antibody |
| 11/17/2005 | US20050255088 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer |